Physician follow-up of pediatric and young adult emergency department visits for substance use in Ontario, Canada
Rosic T, Cloutier P, Myran D, Imsirovic H, Kurdyak P, Gardner W. J Adolesc Health. 2024; S1054-139X(24)00303-3. Epub 2024 Aug 14.
Publications
Secondary stroke prevention in people with schizophrenia
Kapral MK, Porter J, Kurdyak P, Yu AYX, Matheson E, Fang J, Casaubon LK, Kapoor E, Sheehan KA. J Am Heart Assoc. 2024; Jul 26 [Epub ahead of print].
Antipsychotic discontinuation and new trazodone use in Ontario nursing homes: evidence of medication substitution
Harris DA, Maclagan LC, Pequeno P, Iaboni A, Austin PC, Rosella LC, Guan J, Maxwell CJ, Bronskill SE. JAMDA. 2024; 25(9):e105113. Epub 2024 Jun 26.
Maternal disability and newborn discharge to social services: a population-based study
Grant C, Lunsky Y, Guttmann A, Vigod SN, Sharpe I, Fung K, Brown HK. IJPDS. 2024; 9(2). Epub 2024 Jul 4.
Uptake of COVID-19 vaccination among community-dwelling individuals receiving healthcare for substance use disorder and major mental illness: a matched retrospective cohort study
Richard L, Holland A, Aghanya V, Campitelli MA, Hwang SW. Front Public Health. 2024; 12:1426152.
Participation in Special Olympics reduces the rate for developing diabetes in adults with intellectual and developmental disabilities
Lloyd M, Temple V, Foley J, Yeatman S, Lunsky Y, Huang A, Balogh R. Diabet Med. 2024; Jun 25 [Epub ahead of print].
Participation in Special Olympics reduces the rate for developing diabetes in adults with intellectual and developmental disabilities
Lloyd M, Temple VA, Foley JT, Yeatman S, Lunsky Y, Huang A, Balogh R. Diabet Med. 2024; e15393. Epub 2024 Jun 25.
Mental health service use before first diagnosis of a psychotic disorder
Tempelaar W, Kozloff N, Mallia E, Voineskos A, Kurdyak P. JAMA Psych. 2024; Jun 18 [Epub ahead of print].
Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study
McCarthy SDS, Xiao J, Pugliese M, Perrault-Sequeira L, Myran DT. Lancet Reg Health Am. 2024; 36:100815. Epub 2024 Jun 13.
Impact of COVID-19 on psychoactive medication use among individuals with intellectual and developmental disabilities in Ontario, Canada: a repeated cross-sectional study
Guan Q, Garg R, McCormack D, Lunsky Y, Tadrous M, Campbell T, Gomes T. Disabil Health J. 2024; Jun 12 [Epub ahead of print].